Heron Therapeutics Inc.

NASDAQ: HRTX · Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 15, 2025, 3:59 PM
1.33
-0.23%
After-hours: Aug 15, 2025, 05:03 PM EDT

Heron Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-931K -7.79M -13.58M -27.97M -48.13M -80.95M -110.56M -119.7M -136.6M -150.9M -182.02M -216.8M -227.3M -231.96M -220.68M -228.32M -234.14M -228.31M
Depreciation & Amortization
2.32M 2.35M 2.49M 2.63M 2.77M 2.87M 2.9M 2.98M 2.95M 2.89M 2.89M 2.89M 2.94M 3M 3.02M 2.94M 2.95M 2.96M
Stock-Based Compensation
10.32M 12.1M 12.96M 14.99M 18.95M 28.28M 32.85M 39.04M 43.56M 40.01M 42.98M 45.35M 45.39M 46.28M 46.85M 50M 49.86M 49.73M
Other Working Capital
-6.03M -15.6M -6.28M -2M -9.6M 14.74M 12.93M -3.55M -3.48M -8.43M 12.81M 21.8M 20.12M -15M -38.23M -23.62M -7.46M 351K
Other Non-Cash Items
-8.58M -5.84M -6.06M -5.53M 3.14M 354K 413K -589K -845K -817K -251K 244K 496K 699K 904K 1.27M 1.57M 1.62M
Deferred Income Tax
n/a n/a n/a -819K -1M -1.19M -1.19M -367K -183K n/a n/a 1.05M 1.26M 1.5M 1.63M 1.45M 1.37M 1.19M
Change in Working Capital
-31.28M -22.71M -18.34M 8.4M 3.42M 7.23M 16.79M -20.14M -35.55M -19.05M -10.51M 12.62M 6.47M -24.88M -35.08M -37.99M -21.15M -21.02M
Operating Cash Flow
-28.15M -21.88M -22.53M -8.29M -20.84M -43.41M -58.79M -98.78M -126.67M -127.87M -146.91M -154.64M -170.74M -205.35M -203.35M -210.65M -199.54M -193.82M
Capital Expenditures
-1.39M -1.81M -1.71M -1.32M -1.68M -1.32M -1.54M -1.71M -961K -1M -1.82M -1.8M -3.29M -3.28M -3.02M -5.13M -4.23M -4.66M
Cash Acquisitions
80K 69K 27K 13K 22.44M 8.95M -28.11M -28.12M -50.38M -56.97M -19.85M -16.35M -16.52M 3.56M 3.5M n/a n/a n/a
Purchase of Investments
-70.07M -88.1M -103.09M -114.09M -124.38M -111.61M -87.66M -82.88M -115.12M -121.6M -145.68M -165.01M -126.12M -123.19M -129.22M -133.29M -129.14M -149.14M
Sales Maturities Of Investments
96.38M 109.55M 123.48M 113.86M 97.31M 95.36M 107.19M 113.44M 131.94M 145M 143.96M 136.96M 157.4M 174.4M 164.94M 252.19M 281.45M 294.6M
Other Investing Acitivies
n/a n/a n/a n/a -22.43M -8.93M 28.13M 30.56M 16.99M 23.57M -13.43M -19.34M 39.83M 59.77M 56.15M 118.9M 152.31M 145.46M
Investing Cash Flow
25M 19.71M 18.71M -1.54M -28.73M -17.56M 18M 28.85M 16.03M 22.56M -3.32M -29.6M 28.08M 48.02M 32.73M 113.78M 148.09M 140.8M
Debt Repayment
n/a n/a n/a -29.75M 24.35M 24.35M 24.35M 54.1M n/a n/a n/a n/a -19K -19K -19K -19K n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -52K -52K -52K -52K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
781K n/a n/a n/a n/a 319K 111K 550K 75.49M 75.49M 75.06M 75.11M 165K 154.58M 156.1M 161.37M 161.9M 9.48M
Financial Cash Flow
1.28M 993K 940K 716K 54.5M 54.33M 54.11M 54.35M 75.49M 75.49M 75.06M 75.11M 94K 154.51M 156.03M 161.3M 161.9M 9.48M
Net Cash Flow
-1.87M -1.18M -2.88M -9.12M 4.92M -6.64M 13.31M -15.58M -35.15M -29.82M -75.18M -109.13M -142.56M -2.83M -14.6M 64.43M 110.44M -43.55M
Free Cash Flow
-29.53M -23.7M -24.23M -9.61M -22.52M -44.73M -60.33M -100.49M -127.63M -128.88M -148.74M -156.44M -174.02M -208.63M -206.38M -215.78M -203.76M -198.48M